'Assessing QbTest Utility in ADHD' (AQUA) is an NIHR CLAHRC East Midlands trial with MindTech providing clinical leadership (PI: Prof Chris Hollis) and technological support. The project arose out of the MindTech partnership with the SME QbTech Ltd.

The aim is to assess in a randomised controlled trial (RCT) whether providing clinicians and patients with the results of an objective test of activity and attention (QbTest) leads to earlier correct diagnosis of Attention Deficit/Hyperactivity Disorder (ADHD). A secondary objective is to assess whether the QbTest leads to earlier optimisation of treatment and improved patient outcomes in ADHD in routine NHS settings.

More information: http://www.clahrc-em.nihr.ac.uk/clahrc-em-nihr/research/enhancing-mental-health/index.aspx

See publications page for the published protocol in BMJ Open (Trial registration number NCT02209116).